Will a bill curbing pharmaceutical monopolies become law?
As of Fri, 20 Nov 2026 11:53:24 UTC, Kalshi traders price Yes (4.0%). The market has $2K in volume and closes on Mon, 04 Jan 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| Yes | 4.0% | 4.0¢ | 96.0¢ |
Market details
- Venue: Kalshi
- Volume: $2K
- Liquidity: $2K
- Closes:
Resolution rules
If a bill titled "Patients Before Monopolies Act," or an equivalent bill aimed at curbing monopolistic practices (specifically joint ownership of PBM and Pharmacy businesses) in the healthcare or pharmaceutical industry, becomes law after Issuance and before Jan 4, 2027, then the market resolves to Yes.
Sources
Related markets
- Will the SAVE Act become law?
- Will the SAVE America Act become law?
- When will FISA be reauthorized again?
- Which bills will become law this year?
- Will the Clarity Act become law?
- Will the cap on gambling loss deduction be changed?
More markets like this
- Will a congressional term-limits amendment be ratified?
- Will a new Constitutional Amendment be added during Trump's term?
- Will Daylight Saving Time become permanent?
- Will DC come under federal control in 2026?
- Will a bill that directly funds HSAs/FSAs become law?
- Will a cabinet member be impeached?
- Will a country leave BRICS in 2026?
- Will a court block paid early access to Trump's Truth Social posts?
A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.